Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

Cited by (455)

Items 101–200 of 455

1. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
   Catharina Lavebratt, S Olsson, Lena Backlund, Louise Frisén, Carl M. Sellgren, Lutz Priebe, Pernilla Nikamo, Lil Träskman‐Bendz, Sven Cichon, Marquis P. Vawter et al. · 2013 · Molecular Psychiatry
2. Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response
   Hyeon-Sook Suh, Meng‐Liang Zhao, Mark A. Rivieccio, Shinyeop Choi, Erin C. Connolly, Yongmei Zhao, Osamu Takikawa, Celia F. Brosnan, Sunhee C. Lee · 2007 · Journal of Virology
3. Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine
   Verdonk, Franck, Petit, Anne-Cécile, Abdel-Ahad, Pierre, Vinckier, Fabien, Jouvion, Gregory, de Maricourt, Pierre, De Medeiros, Gabriela Ferreira, Danckaert, Anne, Van Steenwinckel, Juliette, Blatzer, Michael et al. · 2019 · Brain, Behavior, and Immunity
4. Tryptophan metabolites in depression: Modulation by gut microbiota
   Iva Lukić, Sanja Ivković, Miloš Mitić, Miroslav Adžić · 2022 · Frontiers in Behavioral Neuroscience
5. Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
   Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, Manon Lebel, Caroline Ménard · 2021 · European Journal of Neuroscience
6. The role of the kynurenine metabolism in major depression
   Aye-Mu Myint, Markus Schwarz, Norbert Müller · 2011 · Journal of Neural Transmission
7. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions
   Strasser, Barbara, Becker, Kathrin, Fuchs, Dietmar, Gostner, Johanna M. · 2017 · Neuropharmacology
8. The Gut Microbiota Links Dietary Polyphenols With Management of Psychiatric Mood Disorders
   Susan Westfall, Giulio Maria Pasinetti · 2019 · Frontiers in Neuroscience
9. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis
   Guillemin, Gilles J., Meininger, Vincent, Brew, Bruce J. · 2005 · Neurodegenerative Diseases
10. Altered kynurenine pathway metabolism in autism: Implication for immune‐induced glutamatergic activity
    C. K. Lim, M. Essa, Roberta de Paula Martins, David B. Lovejoy, Ayse A. Bilgin, M. Waly, Y. Al-Farsi, M. Al-Sharbati, Mohammed A. Al-Shaffae, G. Guillemin · 2016 · Autism Research
11. The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
    Anna Zinger, Carlos Barcia, María Trinidad Herrero, Gilles J. Guillemin · 2011 · Parkinson s Disease
12. Enzymology of mammalian NAD metabolism in health and disease
    Giulio Magni · 2008 · Frontiers in bioscience
13. Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
    Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivènyi, László Vécsei · 2018 · Journal of Alzheimer s Disease
14. LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-γ-independent manner by a JNK signaling pathway in primary murine microglia
    Yunxia Wang, Marcus A. Lawson, Robert Dantzer, Keith W. Kelley · 2009 · Brain Behavior and Immunity
15. Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts
    Braidy, Nady, Gai, Wei-Ping, Xu, Ying Hua, Sachdev, Perminder, Guillemin, Gilles J, Jiang, Xing-Mai, Ballard, J William O, Horan, Martin P, Fang, Zhi Ming, Chong, Beng H et al. · 2013 · Translational Neurodegeneration
16. Fate of microglia during HIV‐1 infection: From activation to senescence?
    Natalie C. Chen, Andrea T. Partridge, Christian Sell, Claudio A. Torres, Julio Martín‐García · 2016 · Glia
17. Methylene Blue Attenuates Traumatic Brain Injury-Associated Neuroinflammation and Acute Depressive-Like Behavior in Mice
    Ashley M. Fenn, John P. Skendelas, Daniel N. Moussa, Megan M. Muccigrosso, Phillip G. Popovich, Jonathan Lifshitz, Daniel Scott Eiferman, Jonathan P. Godbout · 2014 · Journal of Neurotrauma
18. ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain
    YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2016 · Journal of Alzheimer s Disease
19. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells
    Yiu-To Yeung, Nicole S. Bryce, Seray Adams, N. Braidy, Mari Konayagi, K. McDonald, C. Teo, G. Guillemin, Thomas Grewal, Lenka Munoz · 2012 · Journal of Neuro-Oncology
20. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes
    Doolin, Kelly, Allers, Kelly A., Pleiner, Sina, Liesener, Andre, Farrell, Chloe, Tozzi, Leonardo, O’Hanlon, Erik, Roddy, Darren, Frodl, Thomas, Harkin, Andrew et al. · 2018 · Psychoneuroendocrinology
21. Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins
    George Anderson, Michael H. J. Maes · 2013 · Molecular Neurobiology
22. Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons
    N. Braidy, G. Guillemin, R. Grant · 2011 · International Journal of Tryptophan Research
23. Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon
    Karola Obojes, Oliver Andrés, Kwang Sik Kim, Walter Däubener, Jürgen Schneider‐Schaulies · 2005 · Journal of Virology
24. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
    Gislaine Z. Réus, Luana Meller Manosso, João Quevedo, Andre Ferrer Carvalho · 2023 · Neuroscience & Biobehavioral Reviews
25. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
    Jonathan B. Savitz · 2016 · Current topics in behavioral neurosciences
26. Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue
    Sangmi Kim, Brian J. Miller, Michael Edward Stefanek, Andrew H. Miller · 2015 · Cancer
27. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
    Smith, A K, Simon, J S, Gustafson, E L, Noviello, S, Cubells, J F, Epstein, M P, Devlin, D J, Qiu, P, Albrecht, J K, Brass, C A et al. · 2012 · Molecular Psychiatry
28. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors
    Francesco Fazio, Luana Lionetto, Martina Curto, Luisa Iacovelli, Caroline S. Copeland, Stuart A. Neale, Valeria Bruno, Giuseppe Battaglia, T.E. Salt, Ferdinando Nicoletti · 2016 · Neuropharmacology
29. Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons.
    Alexander S. Chiu, M. Gehringer, N. Braidy, G. Guillemin, J. Welch, B. Neilan · 2012 · Toxicon
30. A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder
    Yong‐Ku Kim, Meysam Amidfar, Eunsoo Won · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
31. IDO and TDO as a potential therapeutic target in different types of depression
    Yanjie Qin, Nanxi Wang, Xinlin Zhang, Xuemei Han, Xuejia Zhai, Yongning Lu · 2018 · Metabolic Brain Disease
32. Effects of Kynurenine Pathway Metabolites on Intracellular NAD + Synthesis and Cell Death in Human Primary Astrocytes and Neurons
    Nady Braidy, Ross Grant, Bruce James Brew, Seray Adams, Tharusha Jayasena, Gilles J. Guillemin · 2009 · International Journal of Tryptophan Research
33. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
    Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Mingding Li, Yuping Ning · 2018 · Brain Behavior and Immunity
34. Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices
    Tanja Hochstrasser, Celine Ullrich, Barbara Sperner‐Unterweger, Christian Humpel · 2011 · Neuroscience
35. Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors
    Carlos Eduardo Alves Batista, Csaba Juhász, Otto Muzik, William J. Kupsky, Geoffrey R. Barger, Harry T. Chugani, Sandeep Mittal, Sandeep Sood, Pulak K. Chakraborty, Diane C. Chugani · 2009 · Molecular Imaging and Biology
36. Inflammation and depression: Is there a causal connection with dementia?
    E.Leonard, Brian, Myint, Ayemu · 2006 · Neurotoxicity Research
37. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
    R. Oruch, I. Pryme, B. Engelsen, A. Lund · 2017 · Neuropsychiatric Disease and Treatment
38. Glia in the cytokine-mediated onset of depression: fine tuning the immune response
    Wendy Karen Jo, Yuanyuan Zhang, Hinderk Meiners Emrich, Detlef E. Dietrich · 2015 · Frontiers in Cellular Neuroscience
39. Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
    M. Holtze, Peter Saetre, G. Engberg, L. Schwieler, T. Werge, O. Andreassen, H. Hall, L. Terenius, I. Agartz, Erik G. Jönsson et al. · 2012 · Journal of Psychiatry & Neuroscience
40. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?
    M. Busse, Stefan Busse, A. Myint, T. Gos, H. Dobrowolny, Ulf J. Müller, B. Bogerts, H. Bernstein, J. Steiner · 2015 · European Archives of Psychiatry and Clinical Neuroscience
41. Eucommiae cortex polysaccharides mitigate obesogenic diet-induced cognitive and social dysfunction via modulation of gut microbiota and tryptophan metabolism
    Penghao Sun, Mengli Wang, Zhuoni Li, Jingjing Wei, Feng Liu, Wei Zheng, Xiaoyan Zhu, Xuejun Chai, Shanting Zhao · 2022 · Theranostics
42. DYSFUNCTIONAL KYNURENINE PATHWAY METABOLISM IN THE R6/2 MOUSE MODEL OF HUNTINGTON’S DISEASE
    K. V. Sathyasaikumar, Erin K. Stachowski, Laura Amori, P. Guidetti, P. Muchowski, R. Schwarcz · 2010 · Journal of Neurochemistry
43. The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
    Knut Asbjørn Hestad, Knut Engedal, Jon Elling Whist, Per G. Farup · 2017 · Frontiers in Psychology
44. The known and missing links between Toxoplasma gondii and schizophrenia
    H. Elsheikha, Dietrich Büsselberg, Xing-Quan Zhu · 2016 · Metabolic brain disease
45. The p38-MK2-HuR pathway potentiates EGFRvIII–IL-1β-driven IL-6 secretion in glioblastoma cells
    F. Gurgis, Yiu-To Yeung, Mu-Xin Tang, Benjamin Heng, Michael E. Buckland, A. Ammit, J. Haapasalo, H. Haapasalo, Gilles J. Guillemin, Thomas Grewal et al. · 2014 · Oncogene
46. The Kynurenine Pathway
    Yiquan Chen, Gilles Guillemi · 2012 · InTech eBooks
47. Effects of Sleep Deprivation on the Tryptophan Metabolism
    Abid Bhat, Ananda Staats Pires, Vanessa X. Tan, Saravana Babu Chidambaram, Gilles J. Guillemin · 2020 · International Journal of Tryptophan Research
48. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
    Pratishtha Chatterjee, Henrik Zetterberg, Kathryn G. Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas James Ashton, Abdul Hye, Steve Pedrini, Hamid Reza Sohrabi, Tejal M. Shah et al. · 2019 · Journal of Neuroinflammation
49. The Kynurenine Pathway in Stem Cell Biology
    Simon Jones, G. Guillemin, B. Brew · 2013 · International Journal of Tryptophan Research
50. Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions
    Sen, Zümrüt Duygu, Danyeli, Lena Vera, Woelfer, Marie, Lamers, Femke, Wagner, Gerd, Sobanski, Thomas, Walter, Martin · 2021 · Brain, Behavior, and Immunity
51. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
    Gayathri Sundaram, Chai K. Lim, Bruce James Brew, Gilles J. Guillemin · 2020 · Journal of Neuroinflammation
52. Neuroprotective Effects of a Variety of Pomegranate Juice Extracts against MPTP-Induced Cytotoxicity and Oxidative Stress in Human Primary Neurons
    N. Braidy, Subash Selvaraju, M. Essa, R. Vaishnav, S. Al-Adawi, A. Al-Asmi, H. Al‐Senawi, Ammar Abd Alrahman Alobaidy, Ritu Lakhtakia, G. Guillemin · 2013 · Oxidative Medicine and Cellular Longevity
53. The niacin required for optimum growth can be synthesized from L-tryptophan in growing mice lacking tryptophan-2,3-dioxygenase.
    Miki Terakata, T. Fukuwatari, E. Kadota, Mitsue Sano, Masaaki Kanai, Toshikazu Nakamura, H. Funakoshi, K. Shibata · 2013 · Journal of NutriLife
54. Characterization of the kynurenine pathway in NSC‐34 cell line: implications for amyotrophic lateral sclerosis
    Yi-Quan Chen, Bruce J. Brew, Gilles J. Guillemin · 2011 · Journal of Neurochemistry
55. The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease
    Johanna O. Ojala, Elina M. Sutinen · 2017 · Journal of Clinical Medicine
56. Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress
    Julie E. Finnell, Susan K. Wood · 2016 · Neurobiology of Stress
57. Kynurenines, neurodegeneration and Alzheimer’s disease
    Zsigmond Tamás Kincses, József Toldi, László Vécsei · 2010 · Journal of Cellular and Molecular Medicine
58. Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus
    Alexandra K. Brooks, M. Lawson, Robin A. J. Smith, Tiffany M. Janda, K. Kelley, R. H. McCusker · 2016 · Journal of Neuroinflammation
59. The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
    Lei Qiao, Ge Yang, Peng Wang, Chunlan Xu · 2024 · Pharmacological Research
60. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway
    Martina Ott, Ulrike M. Litzenburger, Katharina J. Rauschenbach, Lukas Bunse, Katharina Ochs, Felix Sahm, Stefan Pusch, Christiane A. Opitz, Jonas Blaes, Andreas von Deimling et al. · 2014 · Glia
61. CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation
    Jingya Yan, Kavitha Kothur, Shekeeb S. Mohammad, Jason Chung, Shrujna Patel, Hannah F Jones, Brooke A. Keating, Velda Xinying Han, Richard Webster, Simone L. Ardern‐Holmes et al. · 2023 · EBioMedicine
62. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
    Pratishtha Chatterjee, Kathryn G. Goozee, Chai K. Lim, IAN R. JAMES, Kaikai Shen, Kelly R. Jacobs, Hamid Reza Sohrabi, Tejal M. Shah, Prita Riana Asih, Preeti Dave et al. · 2018 · Scientific Reports
63. The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
    Timothy Bradley Meier, Jonathan B. Savitz · 2021 · Biological Psychiatry
64. Sodium Butyrate and Indole-3-propionic Acid Prevent the Increase of Cytokines and Kynurenine Levels in LPS-induced Human Primary Astrocytes
    Michelle Lima Garcez, Vanessa X. Tan, Benjamin Heng, Gilles J. Guillemin · 2020 · International Journal of Tryptophan Research
65. Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
    Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, László Vécsei · 2020 · Cells
66. Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
    C. K. Lim, B. Brew, Gayathri Sundaram, G. Guillemin · 2010 · International Journal of Tryptophan Research
67. An integrated cytokine and kynurenine network as the basis of neuroimmune communication
    Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, Nien‐Yi Chiang, Lynda Gail Darlington, Richard O. Williams · 2022 · Frontiers in Neuroscience
68. Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment among HIV-infected Individuals
    Michael R. Keegan, Seetharamaiah Chittiprol, Scott Lee Letendre, Alan Winston, Dietmar Fuchs, Adriano Boasso, Jennifer E. Iudicello, Ronald J. Ellis · 2016 · International Journal of Tryptophan Research
69. The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes
    Valéry Combes, Gilles J. Guillemin, Tailoi Chan‐Ling, Nicholas Henry Hunt, Georges E. Grau · 2012 · Trends in Parasitology
70. Minocycline, a classic antibiotic, exerts psychotropic effects by normalizing microglial neuroinflammation-evoked tryptophan-kynurenine pathway dysregulation in chronically stressed male mice.
    Dan Cheng, Zongshi Qin, Yu Zheng, Jun Xie, Sui-Sha Liang, Jialing Zhang, Yi-Bin Feng, Zhang-Jin Zhang · 2022 · Brain, behavior, and immunity
71. Mind and body: how the health of the body impacts on neuropsychiatry
    Thibault Renoir, Kyoko Hasebe, Laura J. Gray · 2013 · Frontiers in Pharmacology
72. The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders
    A. Kandanearatchi, Bruce J. Brew · 2012 · The FEBS Journal
73. Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain
    Monica A. Williams, Zhi Zhang, E. Nance, J. Drewes, Wojciech G. Lesniak, Sarabdeep Singh, D. Chugani, Kannan M. Rangaramanujam, David R. M. Graham, S. Kannan · 2017 · Developmental Neuroscience
74. Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway
    Caroline M. Forrest, Omari S. Khalil, Mazura Pisar, Kara McNair, Edgar E. Kornisiuk, Marina Snitcofsky, N. Gonzalez, Diana Alicia Jerusalinsky, Lynda Gail Darlington, Trevor W. Stone · 2013 · Neuroscience
75. Changes in the immune system in depression and dementia: causal or coincidental effects?
    Brian E. Leonard, Aye-Mu Myint · 2006 · Dialogues in Clinical Neuroscience
76. Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice
    Carlos R. Dostal, Megan Carson Sulzer, K. Kelley, G. Freund, R. H. McCusker · 2017 · Neurobiology of Stress
77. Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring
    Omari S. Khalil, M. Pisar, C. Forrest, M. C. Vincenten, L. Darlington, Trevor W. Stone · 2014 · European Journal of Neuroscience
78. Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
    Nicholas W. S. Davies, Gilles J. Guillemin, Bruce James Brew · 2010 · International Journal of Tryptophan Research
79. Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity
    Abdur Rahman, M.S. Rama Rao, Khalid M. Khan · 2018 · Journal of Neuroinflammation
80. MOLECULAR ALTERATIONS IN GLIOBLASTOMA: POTENTIAL TARGETS FOR IMMUNOTHERAPY
    A. Haque, N. Banik, S. Ray · 2011 · Progress in Molecular Biology and Translational Science
81. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients
    Gos, Tomasz, Myint, Aye-Mu, Schiltz, Kolja, Meyer-Lotz, Gabriela, Dobrowolny, Henrik, Busse, Stefan, Müller, Ulf J., Mawrin, Christian, Bernstein, Hans-Gert, Bogerts, Bernhard et al. · 2014 · Brain, Behavior, and Immunity
82. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
    Sushama Jadhav, V. Nema · 2021 · Mediators of Inflammation
83. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms
    Gloria Castellano‐González, Kelly R. Jacobs, Emily K. Don, Nicholas James Cole, Seray Adams, Chai K. Lim, David B. Lovejoy, Gilles J. Guillemin · 2019 · Neurotoxicity Research
84. ABCA5 Regulates Amyloid-β Peptide Production and is Associated with Alzheimer's Disease Neuropathology
    YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2014 · Journal of Alzheimer s Disease
85. Neuroprotective Effects of Rosmarinic Acid on Ciguatoxin in Primary Human Neurons
    N. Braidy, A. Matin, F. Rossi, M. Chinain, D. Laurent, G. Guillemin · 2013 · Neurotoxicity research
86. Differential Regulation of Indoleamine-2,3-Dioxygenase (IDO) by HIV Type 1 Clade B and C Tat Protein
    T. Samikkannu, Z. Saiyed, Kurapati V. K. Rao, Dakshayani Kadiyala Babu, José W. Rodríguez, M. N. Papuashvili, M. Nair · 2009 · AIDS Research and Human Retroviruses
87. Stress circuitry: mechanisms behind nervous and immune system communication that influence behavior
    Rose L. Tong, Ubaidah N. Kahn, Laura A. Grafe, Frederick L. Hitti, Nathan T. Fried, Brian F. Corbett · 2023 · Frontiers in Psychiatry
88. Neuroimmunology of depression
    Erika Sarno, Adam James Moeser, Alfred Jay Robison · 2021 · Advances in pharmacology
89. Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
    Vanessa X. Tan, Gilles J. Guillemin · 2019 · Frontiers in Neuroscience
90. Induction of the kynurenine pathway by neurotropic influenza a virus infection
    Maria Holtze, Linnéa Asp, Lilly Schwieler, Göran Engberg, Håkan Karlsson · 2008 · Journal of Neuroscience Research
91. Indoleamine 2,3‐dioxygenase in transplantation (Review Article)
    William R. Mulley, David J. Nikolic‐Paterson · 2008 · Nephrology
92. The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer
    Amir Shadboorestan, Meriem Koual, Julien Dairou, Xavier Coumoul · 2023 · International Journal of Tryptophan Research
93. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder
    M. Öztürk, Şermin Yalın Sapmaz, H. Kandemir, F. Taneli, Ö. Aydemir · 2020 · International journal of clinical practice
94. Neopterin preconditioning prevents inflammasome activation in mammalian astrocytes
    Roberta de Paula Martins, Karina Ghisoni, Chai K. Lim, Aderbal S. Aguiar, Gilles J. Guillemin, Alexandra Latini · 2017 · Free Radical Biology and Medicine
95. Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases
    Ruqayya Afridi, Md Habibur Rahman, Kyoungho Suk · 2022 · Neurobiology of Disease
96. Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy
    Gregory Pal Takacs, Joseph Flores‐Toro, Jeffrey K. Harrison · 2020 · Pharmacology & Therapeutics
97. The kynurenine pathway is involved in bacterial meningitis
    L. G. Coutinho, Stephan Christen, C. Bellac, Fabrícia Lima Fontes, Fladjule Rejane Soares de Souza, D. Grandgirard, S. Leib, L. F. Agnez-Lima · 2014 · Journal of Neuroinflammation
98. Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway.
    M. Pisar, C. Forrest, Omari S. Khalil, K. McNair, M. C. Vincenten, Susana Qasem, L. Darlington, Trevor W. Stone · 2014 · Brain Research
99. Microglia/Macrophage-Derived Inflammatory Mediators Galectin-3 and Quinolinic Acid are Elevated in Cerebrospinal Fluid from Newborn Infants After Birth Asphyxia
    K. Sävman, M. Heyes, Pernilla Svedin, A. Karlsson · 2012 · Translational Stroke Research
100. Microglia as therapeutic target in central nervous system disorders
     Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2020 · Journal of Pharmacological Sciences